Feasibility & Characterization of Project: EVO Monitor Cognitive Measurements

Completed · Not applicable

Conditions studied: Healthy

In brief

This is an open-label study in adults to assess at-home Project: EVO Monitor measurements over repeat play cycles. The study has three arms:playing multiple times per day, once daily, and once weekly for 4 to 8 weeks.

Key facts

Study ID

NCT02792296

Run by

Akili Interactive Labs, Inc.

People needed

71

Starts

2016-06-01

Expected to finish

2016-11-01

Last updated by the study team

2016-11-07

Who can join

Age: 40 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age: 40-55 at the time of informed consent
• Ability to follow written and verbal instructions (English).
• Male and Female (Gender-matched).
• Ability to comply with all the testing and requirements.

You may not qualify if…

• Current, controlled (requiring a restricted medication) or uncontrolled, self-reported psychiatric diagnosis with significant symptoms such as post-traumatic stress disorder, psychosis, bipolar illness, pervasive developmental disorder, severe obsessive compulsive disorder, severe depressive or severe anxiety disorder, conduct disorder, attention deficit disorder, autism spectrum disorder, or other symptomatic manifestations that in the opinion of the Investigator that may confound study data/assessments.
• Current self-reported community diagnosis of cognitive ailments such as dementia, Alzheimer's disease, stroke, traumatic brain injury, or other diseases that in the opinion of the Investigator that may confound study data/assessments.
• Current diagnosis of severe learning disorder, dyslexia, or dyscalculia.
• Current subjective complaints of inattention or memory loss.
• Current use of psychotropic medication, prescription or otherwise.
• Currently undergoing psychotherapy, behavioral therapy, or occupational therapy.
• Motor condition that prevents game playing, as observed by investigator.
• Impaired visual acuity, as defined by difficulty reading the informed consent even with corrective lenses.
• Recent history (within the past 6 months) of suspected substance abuse or dependence.
• History of seizures (exclusive of febrile seizures), a tic disorder, significant tics, a current diagnosis of Tourette's Disorder.
• Taken part in a clinical trial within 30 days prior to screening.
• Diagnosis of color blindness.
• Regular use of psychoactive drugs that in the opinion of the Investigator may confound study data/assessments
• Any other medical condition that in the opinion of the investigator may confound study data/assessments.

Where it is running

• Preferred Research Partners — Little Rock, Arkansas, United States
• Clinical Trials of Texas — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.